The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 601–700 of 1,003
Morus alba extract modulates blood pressure homeostasis through eNOS signaling
Carrizzo, A., Ambrosio, M., Damato, A., Madonna, M., Storto, M., Capocci, L., Campiglia, P., Sommella, E., Trimarco, V., Rozza, F., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600233 · Cited by 43
Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent Hypoxia
Badran, M., Abuyassin, B., Golbidi, S., Ayas, N., & Laher, I. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2354870 · Cited by 43
“The function of eNOS is compromised in diseases such as diabetes and hypertension, where eNOS produces superoxide anion instead of NO by a process termed “eNOS uncoupling” [41].”
BackgroundEffects of resveratrol on eNOS in the endothelium and the perivascular adipose tissue
Xia, N., Förstermann, U., & Li, H. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13397 · Cited by 44
Conen, D., Glynn, R. J., Buring, J. E., Ridker, P. M., & Zee, R. Y. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283077eef · Cited by 43
Relevance of nitric oxide for myocardial remodeling
Massion, P. B., & Balligand, J. (2007) · Current Heart Failure Reports · doi:10.1007/s11897-007-0021-6 · Cited by 42
“sensitive to oxidation by peroxynitrite [ 15 ], leading to aggravated uncoupling.”
BackgroundYang, J., Ambrosone, C. B., Hong, C.-C., Ahn, J., Rodríguez, C., Thun, M. J., & Calle, E. E. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm016 · Cited by 43
“Secondly, smoking can oxidize tetrahydrobiopterin (BH4), an essential cofactor of eNOS, which causes the enzyme to produce ROS instead of NO leading to increased oxidative stress ( 7 ,29).”
BackgroundMechanisms of Arsenic Exposure-Induced Hypertension and Atherosclerosis: an Updated Overview
Balarastaghi, S., Rezaee, R., Hayes, A. W., Yarmohammadi, F., & Karimi, G. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03153-2 · Cited by 41
Role of resveratrol in inhibiting pathological cardiac remodeling
Fan, S., Hu, Y., You, Y., Xue, W., Chai, R., Zhang, X., Shou, X., & Shi, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924473 · Cited by 44
“of oxidative stress induced by eNOS uncoupling, expand blood vessels, improve smooth muscle cell proliferation, vascular remodeling and arterial stiffness, and inhibit the progress of cardiac remodeling (Förstermann and Münzel, 2006; Li and Förstermann, 2013).”
BackgroundSphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
Piccoli, M., Cirillo, F., Ghiroldi, A., Rota, P., Coviello, S., Tarantino, A., Rocca, P. L., Lavota, I., Creo, P., Signorelli, P., et al. (2023) · Antioxidants · doi:10.3390/antiox12010143 · Cited by 45
Role of Endothelium in Cardiovascular Sequelae of Long COVID
Santoro, L., Zaccone, V., Falsetti, L., Ruggieri, V., Danese, M., Miro, C., Giorgio, A. D., Nesci, A., D’Alessandro, A., Moroncini, G., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11082239 · Cited by 45
Ryan, D. J., Stebbings, G. K., & Onambélé-Pearson, G. L. (2015) · AGE · doi:10.1007/s11357-015-9832-7 · Cited by 46
“2013), which can cause nitric oxide synthase (eNOS) uncoupling and subsequently, downregulation of NO (Förstermann and Münzel 2006).”
BackgroundHennekens, C. H., & Dalen, J. E. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.013 · Cited by 42
Association of Aging, Arterial Stiffness, and Cardiovascular Disease
Veerasamy, M., Ford, G. A., Neely, D., Bagnall, A. J., MacGowan, G. A., Das, R., & Kunadian, V. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000009 · Cited by 44
“In addition, vascular tone is influenced by autocrine and paracrine mediators such as angiotensin II,(11) endothelins,(12) oxidative stress,(13) and nitric oxide.(14) Increased expression of the nitric oxide synthase inhibitor, asymmetrical dimethyl arginine, has also been linked to vascular stiffening.”
BackgroundModeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production
Kar, S., & Kavdia, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.009 · Cited by 42
“The reductase domain contains binding sites for the flavin cofactors FAD and FMN and the substrate NADPH [1,3].”
BackgroundInfluentialFolic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model
Ahmad, S., Panda, B. P., Kohli, K., Fahim, M., & Dubey, K. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1299768 · Cited by 42
Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death
Shukla, K., Sonowal, H., Saxena, A., & Ramana, K. V. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.012 · Cited by 42
Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics
Singh, N., Sherin, G. R., & Mugesh, G. (2023) · Angewandte Chemie · doi:10.1002/ange.202301232 · Cited by 43
Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction
Zhang, Y., Wang, J., He, M., Liu, J., Zhao, J., He, J., Wang, C., Li, Y., Xiao, C., Fan, C., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103675 · Cited by 44
van de Pol, V., Kurakula, K., DeRuiter, M. C., & Goumans, M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00938 · Cited by 41
Antithrombotic components of Malus halliana Koehne flowers
Cui, L., Xing, M., Xu, L., Wang, J., Zhang, X., Ma, C., & Kang, W. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.049 · Cited by 41
Zhou, L., Li, X., Wang, K., Shen, F., Zhang, L., Li, P., Shang, T., Wang, J., & Huang, N. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbz043 · Cited by 41
“NO also plays an important role in regulating the mitosis and proliferation of SMC and inhibiting the adhesion and aggregation of platelets [14].”
BackgroundTakotsubo Syndrome: Impact of endothelial dysfunction and oxidative stress
Münzel, T. F., Templin, C., Cammann, V. L., & Hahad, O. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.033 · Cited by 43
Reactive Oxygen Species in Diabetes-induced Vascular Damage, Stroke, and Alzheimer's Disease
Muhammad, S., Bierhaus, A., & Schwaninger, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0982 · Cited by 42
“and eNOS uncoupling contribute to O2 production [14, 24,25].”
BackgroundSherratt, S. C. R., Libby, P., Bhatt, D. L., & Mason, R. P. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102450 · Cited by 49
The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury
Frantz, S., Adamek, A., Fraccarollo, D., Tillmanns, J., Widder, J. D., Dienesch, C., Schäfer, A., Podolskaya, A. A., Held, M. C., Ruetten, H., et al. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0041-3 · Cited by 41
“tetrahydrobiopterin [9].”
Melatonin as an Antioxidant Agent in Stroke: An Updated Review
Wang, J., Gao, S., Lenahan, C., Gu, Y., Wang, X., Fang, Y., Xu, W., Wu, H., Pan, Y., Shao, A., et al. (2022) · Aging and Disease · doi:10.14336/ad.2022.0405 · Cited by 40
Senescent endothelial cells: a potential target for diabetic retinopathy
Liao, Y.-L., Fang, Y., Sun, J., & Dou, G. (2024) · Angiogenesis · doi:10.1007/s10456-024-09943-7 · Cited by 40
Atherosclerosis, Caveolae and Caveolin-1
Pavlides, S., Gutiérrez-Pajares, J. L., Danilo, C., Lisanti, M. P., & Frank, P. G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1222-9_9 · Cited by 40
Schuhmacher, S., Schulz, E., Oelze, M. W., König, A., Roegler, C., Lange, K., Sydow, L., Kawamoto, T., Wenzel, P., Münzel, T. F., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00303.x · Cited by 40
“Endothelial dysfunction has been identified as a hall-mark of most cardiovascular diseases (Cai and Harrison, 2000) and is always associated with vascular oxidative stress, decreased NO bioavailability and/or impaired activity (uncoupling) of endothelial NO synthase (Munzel et al., 2005b; Forstermann and Munzel, 2006).”
BackgroundBattault, S., Singh, F., Gayrard, S., Zoll, J., Reboul, C., & Meyer, G. (2015) · Hypertension Research · doi:10.1038/hr.2015.114 · Cited by 44
Lee, J. H., Parveen, A., Do, M. H., Lim, Y., Shim, S. H., & Kim, S. Y. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.05.005 · Cited by 40
Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis
Rasheed, A., & Cummins, C. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082307 · Cited by 40
“During atherogenesis, eNOS function is perturbed leading to decreased production of nitric oxide, or even a production of oxidative species that further potentiate defects to the endothelium, which can occur through nitric oxide scavenging and conversion to the pathogenic peroxynitrite species [14,15].”
BackgroundGawryś, J., Gajecki, D., Szahidewicz-Krupska, E., & Doroszko, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1015908 · Cited by 40
“Peroxynitrite is a potent oxidative compound which promotes posttranslational modifications of proteins (including the eNOS protein) [19], alterations in the main metabolic pathways [20], or eNOS uncoupling which results in the production of superoxide anion instead of NO [21, 22].”
Backgroundde Castro, A. L., Tavares, Â. M. V., Fernandes, R. O., Carraro, C. C., Conzatti, A., Siqueira, R., Fernandes, T. R. G., Schenkel, P. C., Sartório, C. L., Llesuy, S., et al. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2501-4 · Cited by 39
“However, after heart failure, the bioavailability of eNOS-derived NO is severely reduced [38, 39].”
The failing diabetic heart: Focus on diastolic left ventricular dysfunction
van Heerebeek, L., Somsen, G. A., & Paulus, W. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0014-9 · Cited by 40
“Evidence for uncoupling of eNOS has been obtained in patients with DM, hypertension, and hypercholesterolemia [ 22 ].”
MethodResultVázquez‐Lorente, H., Herrera‐Quintana, L., Jiménez-Sánchez, L., Fernández-Perea, B., & Plaza‐Díaz, J. (2024) · Antioxidants · doi:10.3390/antiox13080996 · Cited by 44
“The NOS pathway is essential for maintaining vascular homeostasis and preventing endothelial dysfunction [104].”
Wu, T. S., Jiang, B., Wang, Y., Yin, A., Huang, C., Wang, S., & Mo, X. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00599j · Cited by 39
Saboo, A., Rathnayake, A., Vangaveti, V., & Malabu, U. H. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.006 · Cited by 39
Optimal serum phenylalanine for adult patients with phenylketonuria
Okano, Y., & Nagasaka, H. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.09.007 · Cited by 39
“mechanismof thedecrease inNOx in the secondphase at higher phenylalanine levels, we speculate that transcriptional suppression of the NOS gene or structural changes in NOS are induced under markedly enhanced oxidative stress [26,27].”
BackgroundNanotopography and Plasma Treatment: Redesigning the Surface for Vascular Graft Endothelialisation
Chong, D., Turner, L.-A., Gadegaard, N., Seifalian, A. M., Dalby, M. J., & Hamilton, G. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.12.008 · Cited by 39
The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling
Farsetti, A., Grasselli, A., Bacchetti, S., Gaetano, C., & Capogrossi, M. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91360.2008 · Cited by 39
“Interestingly, several reports have demonstrated that hTERT is also induced by medications, such as aspirin, statins, and thiazolidinediones (2, 8, 14, 41) known to exert a beneficial effect on cardiovascular diseases.”
BackgroundHan, F., Tao, R., Zhang, G., Lu, Y., Liu, L., Chen, Y.-X., Lou, Y.-J., Fukunaga, K., & Hong, Z.-H. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00838.x · Cited by 39
“Indeed, increasing evidence also indicates that eNOS uncoupling/ peroxynitrite formation is a biochemical vicious cycle associated with vascular endothelial injury [33, 34].”
BackgroundPulse pressure-dependent cerebrovascular eNOS regulation in mice
Raignault, A., Bolduc, V., Lesage, F., & Thorin, É. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16629155 · Cited by 39
“Such a ‘‘switch’’ in eNOS activity from NO to O 2 =H2O2 production is referred to as eNOS uncoupling and is usually associated with cardiovascular diseases.(32) Nonetheless, it has been shown that nNOS-derived H2O2 accounted for Ach-induced relaxation of aortic rings isolated from healthy C57Bl6 mice.”
BackgroundChen, Z. B., Martin, M., Zhao, L., & Shyy, J. Y.-J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000107 · Cited by 40
“In addition to regulating vascular tone, nitric oxide has several beneficial effects against atherosclerosis, including antiinflammation, antioxidation, and antiproliferation of smooth muscle cells as well as inhibiting the adhesion and infiltration of leukocytes (as reviewed in [9]).”
BackgroundSelenium and selenoproteins: from endothelial cytoprotection to clinical outcomes
Lopes, E., Leite, H. P., & Konstantyner, T. (2019) · Translational research · doi:10.1016/j.trsl.2019.01.004 · Cited by 39
Xie, X., Deng, T., Duan, J., Ding, S., Yuan, J., & Chen, M. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.02.067 · Cited by 39
Valaei, K., Taherkhani, S., Arazi, H., & Suzuki, K. (2021) · Nutrients · doi:10.3390/nu13103483 · Cited by 41
“Endothelial NO synthase can be “uncoupled” by ONOO−, leading to dysfunction of the O2-producing enzyme, resulting in vascular oxidative stress [23,25].”
BackgroundNitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment
Siuta, M., Zuckerman, S. L., & Mocco, J. (2013) · Neurology Research International · doi:10.1155/2013/972417 · Cited by 41
MicroRNA and Mechanisms of Impaired Angiogenesis in Diabetes Mellitus
Leeper, N. J., & Cooke, J. P. (2011) · Circulation · doi:10.1161/circulationaha.110.003855 · Cited by 40
Environmental Toxins and Oxidative Stress: The Link to Cardiovascular Diseases
Sule, R. O., Rivera, G. D. T., Vaidya, T., Gartrell, E., & Gomes, A. V. (2025) · Antioxidants · doi:10.3390/antiox14050604 · Cited by 41
Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling
Yuan, S. S., & Kevil, C. G. (2015) · Microcirculation · doi:10.1111/micc.12248 · Cited by 37
“The heme also receives a second electron from BH4 in the oxidase domain, resulting in O2 production and BH4 oxidation [36].”
BackgroundInfluentialSOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2 diabetic mice
Fujita, H., Fujishima, H., Takahashi, K., Sato, T. K., Shimizu, T., Morii, T., Shimizu, T., Shirasawa, T., Qi, Z., Breyer, M. D., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.005 · Cited by 38
“[44] Forstermann U, Munzel T.”
BackgroundDong, Y., Wu, Y., Wu, M., Wang, S., Zhang, J., Xie, Z., Xu, J., Song, P., Wilson, K., Zhao, Z., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00416.x · Cited by 40
“Under normal conditions, endothelial nitric oxide synthase (eNOS) generates the vasoprotective molecule, nitric oxide [9, 10].”
BackgroundZhang, J., Jie-ren, Y., Chen, G., Tang, L.-J., Li, W., Yang, H., & Kong, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.1 · Cited by 38
Increasing dihydrobiopterin causes dysfunction of endothelial nitric oxide synthase in rats in vivo
Noguchi, K., Hamadate, N., Matsuzaki, T., Sakanashi, M., Nakasone, J., Uchida, T., Arakaki, K., Kubota, H., Ishiuchi, S., Masuzaki, H., et al. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01089.2010 · Cited by 38
Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Rana, S., Kumar, S., Rathore, N., Padwad, Y. S., & Bhushan, S. (2016) · Current Genomics · doi:10.2174/1389202917666160202220422 · Cited by 40
“L-arginine found to have beneficial effect in hypercholesterolemia in animals as well as humans [68].”
Transcriptional and Posttranslational Regulation of eNOS in the Endothelium
Fulton, D. J. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.04.001 · Cited by 37
New Insights in the Pathophysiology of Antiphospholipid Syndrome
Sacharidou, A., Shaul, P. W., & Mineo, C. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1597286 · Cited by 38
Gielis, J. F., Beckers, P. A. J., Briedé, J. J., Cos, P., & Schil, P. E. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.32 · Cited by 38
Moroni, L., Selmi, C. F., Angelini, C., & Meroni, P. L. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0465-7 · Cited by 37
Walton, D. M., Minton, S. D., & Cook, A. D. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.003 · Cited by 39
Wal, P., Saraswat, N., Pal, R. S., Wal, A., & Chaubey, M. (2019) · Open Medicine Journal · doi:10.2174/1874220301906010064 · Cited by 38
Zhai, R., Xu, H., Hu, F., Wu, J., Kong, X., & Sun, X. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15059 · Cited by 38
“In several diseases such as diabetes and hypertension, the uncoupling of eNOS characterizes the endothelial dysfunction, as it decreases production of NO and increases the generation of superoxide (Forstermann & Munzel, 2006).”
BackgroundKayki‐Mutlu, G., & Koch, W. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020521 · Cited by 39
“Conversely, increased eNOS is also reported to be associated with a cardiovascular risk due to excess ROS production [30].”
BackgroundZhao, Y., Xi, Q., Xu, Q., He, M., Ding, J., Dai, Y., Keller, N. P., & Zheng, W. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6367-2 · Cited by 38
High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
Mohan, S., Konopiński, R., Yan, B., Centonze, V. E., & Natarajan, M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00575.2007 · Cited by 38
Li, G., del Rincon, J. P., Jahn, L. A., Wu, Y., Gaylinn, B. D., Thorner, M. O., & Liu, Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2021 · Cited by 39
Münzel, T. F., & Daiber, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0006 · Cited by 40
“…of inhibition of eNOS since uncoupling causes the enzyme to change from an NO to O2 - donor, thereby changing the biological environment from a vasodilator/antiatherosclerotic and thus beneficial to a harmful/proatherosclerotic phenotype (Forstermann and Munzel, 2006; Munzel et al, 2005b).”
BackgroundInfluentialLi, J., Liao, R., Zhang, S., Weng, H., Liu, Y., Tao, T., Yu, F., Li, G., & Wu, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154867 · Cited by 37
Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives
Xie, P.-L., Zheng, M.-Y., Han, R., Chen, W., & Mao, J.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366061 · Cited by 40
“Disruptions in the process are commonly associated with disease (Förstermann and Münzel, 2006).”
BackgroundWeiss, N., Papatheodorou, L., Morihara, N., Hilge, R., & Ide, N. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.045 · Cited by 37
Role of Arginine Guanidinium Moiety in Nitric-oxide Synthase Mechanism of Oxygen Activation
Giroud, C., Moreau, M., Mattioli, T. A., Balland, V., Boucher, J., Li, Y., Stuehr, D. J., & Santolini, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038240 · Cited by 37
Zhang, W., Han, Y., Meng, G., Bai, W., Xie, L., Lu, H., Shao, Y., Wei, L., Pan, S., Zhou, S., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000606 · Cited by 37
“NO scavenges superoxide anion and protects against impairment of vascular endothelial function.(24,25) There is accumulating evidence that oxidative stress induces I/R injury, and reactive oxygen species and free radicals have long been recognized as major mediators of I/R injury.”
BackgroundXu, C., Tang, F., Lü, M., Yang, J., Han, R., Mei, M., Hu, J., & Wang, H. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0572 · Cited by 37
AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy
Hollanders, K., Hove, I. V., Sergeys, J., Bergen, T. V., Lefevere, E., Kindt, N., Castermans, K., Vandewalle, E., van Pelt, J. F., Moons, L., et al. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1183030 · Cited by 38
Soares, R. N., & Murias, J. M. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.01.008 · Cited by 37
Lopez, M., Lax, A., Vicente, Á. H., Guillen, E. S., Hernández-Martínez, A. M., del Palacio, M. J. F., Bayés‐Genís, A., & Pascual-Figal, D. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70454-8 · Cited by 37
Silva, E. A. P., dos Santos, D. M., de Carvalho, F. O., de Menezes, I. A. C., Barreto, A. S., Souza, D. S., Quintans‐Júnior, L. J., & dos Santos, M. R. V. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153451 · Cited by 37
A high-performance genetically encoded fluorescent biosensor for imaging physiological peroxynitrite
Chen, Z., Zhang, S., Li, X., & Ai, H. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.013 · Cited by 35
Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies
Sahebnasagh, A., Saghafi, F., Negintaji, S., Hu, T., Shabani-Borujeni, M., Safdari, M., Ghaleno, H. R., Miao, L., Qi, Y., Wang, M., et al. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210707194543 · Cited by 39
Higashikuni, Y., Liu, W., Obana, T., & Sata, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112081 · Cited by 38
“Nitric oxide also inhibits thromboinflammation and reactive oxygen species production by acting on endothelial cells [207].”
BackgroundHeme oxygenase-1 in cardiovascular diseases: molecular mechanisms and clinical perspectives.
Wang, C., & Chau, L. (2010) · PubMed · Cited by 36
Fat intake and cardiovascular response
Damjanovi, M., & Barton, M. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0007-0 · Cited by 38
Parodi, O., Maria, R. D., & Roubina, E. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32801194d4 · Cited by 37
Weibel–Palade bodies—sentinels of acute stress
Goligorsky, M. S., Patschan, D., & Kuo, M. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.87 · Cited by 37
“This preliminary finding, in conjunction with the well-established uncoupled state of endothelial nitric oxide synthase in dysfunctional endothelial cells”
ResultNitric oxide and kidney oxygenation
Palm, F., Teerlink, T., & Hansell, P. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831c4cdf · Cited by 37
Djuric, D. M., Vušanović, A., & Jakovljevic, V. L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9381-6 · Cited by 38
“Furthermore, there is evidence that vitamin C may have direct effects on activity of NOS, possibly through an effect on tetrahydrobiopterin (Heller et al. 1999; Huang et al. 2000; Förstermann and Münzel 2006).”
BackgroundIncreased Oxidant Activity Mediates Vascular Dysfunction in Vibration Injury
Hughes, J. M., Wirth, O., Krajnak, K., Miller, R., Flavahan, S., Berkowitz, D. E., Welcome, D. E., & Flavahan, N. A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144618 · Cited by 37
“NO is vasoprotective and acts to inhibit platelet aggregation and adhesion and vascular remodeling and inflammation, whereas H2O2 and other oxidants can initiate pathological changes in the vasculature, stimulating inflammatory genes, vascular remodeling, and enhanced vasoconstriction (Boulden et al., 2006; Försterman…”
BackgroundTaguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2012) · Endocrinology · doi:10.1210/en.2012-1101 · Cited by 36
“eNOS and Akt play a major role in the regulation of vascular endothelial function (31, 35), and these are consistent with previous data demonstrating that Akt phosphorylation leads to eNOS phosphorylation and subsequent activation of eNOS enzymatic activity (13–16, 36, 37).”
ResultToyama, K., Nakamura, T., Kataoka, K., Yasuda, O., Fukuda, M., Tokutomi, Y., Dong, Y., Ogawa, H., & Kim‐Mitsuyama, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.012 · Cited by 36
The discovery of endothelium-dependent contraction: The legacy of Paul M. Vanhoutte
Barton, M. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.013 · Cited by 39
Lee, G., Lee, H., Choi, M., Choi, A.-H., Shin, T.-S., & Chae, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.035 · Cited by 36
Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome
Jahandideh, F., & Wu, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062192 · Cited by 36
“GMP mediates vasodilatation by decreasing smooth muscle tone through a reduction in the concentration of intracellular Ca2+ or reduced sensitivity to this ion [38,39].”
BackgroundProtein O‐GlcNAcylation in the heart
Ng, Y. H., Okolo, C. A., Erickson, J. R., Baldi, J. C., & Jones, P. P. (2021) · Acta Physiologica · doi:10.1111/apha.13696 · Cited by 36
Skeletal Muscle Nitrate as a Regulator of Systemic Nitric Oxide Homeostasis
Piknova, B., Schechter, A. N., Park, J. W., Vanhatalo, A., & Jones, A. M. (2021) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000272 · Cited by 38
Accelerated atherosclerosis in rheumatoid arthritis: a systematic review
Raj, R., Thomas, S., & Gorantla, V. R. (2022) · F1000Research · doi:10.12688/f1000research.112921.1 · Cited by 50
Ketonen, J., & Mervaala, E. M. A. (2008) · Heart and Vessels · doi:10.1007/s00380-008-1066-5 · Cited by 36
Superoxide Generation from Nitric Oxide Synthases
Xia, Y. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1733 · Cited by 36
“Indeed, supplementation with BH 4 or its precursors has been reported to improve endothelial function in a variety of cardiovascular disease models (12, 22, 33).”
Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
Ming, X., Montani, J., & Yang, Z. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00005 · Cited by 36
Plasma Kallikrein Inhibitors in Cardiovascular Disease
Kolte, D. S., & Shariat‐Madar, Z. (2015) · Cardiology in Review · doi:10.1097/crd.0000000000000069 · Cited by 36
“However, NO reacts with O 2 •− to produce ONOO, which uncouples endothelial NO synthase, transforming it from a protective enzyme to a contributor to oxidative stress.(152) HKa produced as a result of HK cleavage by plasma kallikrein increases ROS production in a concentrationdependent manner resulting in accelerated…”
Background
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review